Research and experimental development on natural sciences and engineering
KINN THERAPEUTICS AS
Revenue 2025
NOK 3.0m
Operating profit
NOK 383,000
Equity
NOK 2.6m
Incorporated
2004
Employees
6
Share capital
NOK 105,000
Key figures · 2025
Current ratio
7.72
Equity ratio
87.5%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 12.6% | |
| Net margin (%%) | 12.6% | |
| Return on assets (%%) | 12.7% | |
| Likviditet | ||
| Current ratio | 7.72 | |
| Working capital | 2.5m | |
| Soliditet | ||
| Equity ratio (%%) | 87.5% | |
| Debt-to-equity ratio | 0.14 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.